Genetic alterations defining NSCLC subtypes and their therapeutic implications
Open Access
- 5 September 2013
- journal article
- review article
- Published by Elsevier BV in Lung Cancer
- Vol. 82 (2), 179-189
- https://doi.org/10.1016/j.lungcan.2013.07.025
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes for Health Research (MOP 86731, MOP 94867, MOP-110949)
- Canadian Cancer Society (CCS20485)
- U.S. Department of Defense (CDMRP W81XWH-10-1-0634)
- NCI Early Detection Research Network
- Canary Foundation
- Vanier Canada Graduate Scholarship
This publication has 159 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Identification of RET gene fusion by exon array analyses in “pan-negative” lung cancer from never smokersCell Research, 2012
- Integrating the multiple dimensions of genomic and epigenomic landscapes of cancerCancer and Metastasis Reviews, 2010
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Raf kinases: Function, regulation and role in human cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- LKB1 modulates lung cancer differentiation and metastasisNature, 2007
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectNature, 2007
- Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersInternational Journal of Cancer, 2006
- Mutations of the BRAF gene in human cancerNature, 2002